Intramolecular Diels–Alder reactions of 1-phenylsulfonylalka-1,2,(ω − 3),(ω − 1)-tetraenes
作者:James R. Bull、Richard Gordon、Roger Hunter
DOI:10.1039/b005146m
日期:——
Methods are described for conversion of a series of (E)-alka-(ω − 3),(ω − 1)-dienals 2, via ethynylation to the corresponding alkadienynols 3, followed by sequential [2,3] sigmatropicrearrangement of their derived phenylsulfenate esters and chemoselective oxidation, into 1-phenylsulfonylalka-1,2,(ω − 3),(ω − 1)-tetraenes 5, which are used to study the influence of tether length and peripheral substitution
[EN] ADENOVIRAL VECTOR-MEDIATED DELIVERY OF MODIFIED STEROID HORMONE RECEPTORS AND RELATED PRODUCTS AND METHODS<br/>[FR] APPORT, ASSURE PAR UN VECTEUR ADENOVIRAL, DE RECEPTEURS D'HORMONES STEROIDES MODIFIES, ET PRODUITS ET PROCEDES S'Y RATTACHANT
申请人:VALENTIS INC
公开号:WO2000031286A1
公开(公告)日:2000-06-02
The present invention relates to adenoviral delivery of modified steroid hormone receptor proteins. The adenoviral vector preferably contains no viral coding sequence and is capable of accepting a large insert. Such vectors preferably are capable of achieving high levels and durations of delivery and expression. The modified protein preferably is capable of distinguishing a hormone agonist from an antagonist and may be modified in the ligand binding domain, the DNA binding domain, and/or the transregulatory domain.
[EN] NEW MODULATION MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM<br/>[FR] NOUVELLES MOLÉCULES DE MODULATION DESTINÉES À UN SYSTÈME D'EXPRESSION RÉGULÉE AMÉLIORÉ
申请人:BAYER SCHERING PHARMA AG
公开号:WO2008125222A2
公开(公告)日:2008-10-23
[EN] The present invention provides an improved, expression system for the regulated expression of an encoded protein or nucleic acid therapeutic molecule in the cells of a subject, for use in the treatment of disease. In particular, the present invention provides an improved, regulated gene expression system, and pharmaceutical compositions and uses thereof for treatment of disease. [FR] L'invention concerne un système d'expression amélioré assurant l'expression régulée d'une molécule thérapeutique codée à protéine ou à acide nucléique dans les cellules d'un sujet, utilisé dans le traitement de maladies. Plus particulièrement, elle concerne un système d'expression génétique régulée amélioré, des compositions pharmaceutiques et leurs utilisations dans le traitement de maladies.
Useful Enantioselective Bicyclization Reactions Using an N-Protonated Chiral Oxazaborolidine as Catalyst
作者:Gang Zhou、Qi-Ying Hu、E. J. Corey
DOI:10.1021/ol035542a
日期:2003.10.1
[reaction: see text] Nine examples are reported of enantioselective [4 + 2] cycloaddition reactions of achiral, acyclic substrates to form chiral bicyclo[4.3.0]nonane or bicyclo[4.4.0]decane derivatives.